Search Results - Xiaoping Tu
- Showing 1 - 5 results of 5
-
1
-
2
Crystal Structure of Human CD47 in Complex with Engineered SIRPα.D1(N80A) by Jifeng Yu, Song Li, Dianze Chen, Dandan Liu, Huiqin Guo, Chunmei Yang, Wei Zhang, Li Zhang, Gui Zhao, Xiaoping Tu, Liang Peng, Sijin Liu, Xing Bai, Yongping Song, Zhongxing Jiang, Ruliang Zhang, Wenzhi Tian
Published in Molecules (2022-08-01)Get full text
Article -
3
The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling by Song Li, Dianze Chen, Huiqin Guo, Dandan Liu, Chunmei Yang, Ruliang Zhang, Tianxiang Wang, Fan Zhang, Xing Bai, Yanan Yang, Nana Sun, Wei Zhang, Li Zhang, Gui Zhao, Liang Peng, Xiaoping Tu, Wenzhi Tian, Wenzhi Tian
Published in Frontiers in Oncology (2023-10-01)Get full text
Article -
4
IMM2520, a novel anti-CD47/PD-L1 bispecific antibody for cancer immune therapy by Chunmei Yang, Song Li, Dianze Chen, Dandan Liu, Yanan Yang, Huiqin Guo, Nana Sun, Xing Bai, Guanghui Li, Ruliang Zhang, Tianxiang Wang, Li Zhang, Liang Peng, Sijin Liu, Wei Zhang, Gui Zhao, Xiaoping Tu, Wenzhi Tian
Published in Heliyon (2024-11-01)Get full text
Article -
5
Combining CD38 antibody with CD47 blockade is a promising strategy for treating hematologic malignancies expressing CD38 by Song Li, Dianze Chen, Yanan Yang, Huiqin Guo, Dandan Liu, Nana Sun, Xing Bai, Kaili Wang, Tengfei Li, Guanghui Li, Chunmei Yang, Wei Zhang, Li Zhang, Gui Zhao, Liang Peng, Sijin Liu, Xiaoping Tu, Ruliang Zhang, Wenzhi Tian, Wenzhi Tian
Published in Frontiers in Immunology (2024-06-01)Get full text
Article
